期刊文献+

支气管哮喘患者 Th17细胞的检测及其意义 被引量:2

Detection of Th17 cell in patients with bronchial asthma and itssignificance
原文传递
导出
摘要 目的:检测支气管哮喘患者外周血、肺泡灌洗液中 Th17的表达水平,并探讨其在支气管哮喘发病中的作用及意义。方法收集支气管哮喘急性发作患者52例作为观察组,并且将上述患者根据严重度再分组(重度、中度、轻度);另外选取同时期在该院进行健康体检者50例作为对照组,收集上述病例的外周血及肺泡灌洗液,采用实时荧光定量 PCR 法检测 Th17细胞的特异性转录因子 RORγt 及细胞因子 IL-17在外周血及肺泡灌洗液中的表达水平。结果观察组外周血及肺泡灌洗液中的 IL-17、RORγt 的相对表达量均高于对照组(外周血 IL-17表达量:观察组重度、中度、轻度分别为(1.89±0.09)、(1.02±0.1)、(1.11±0.09),对照组为(0.69±0.12),外周血 IL-17mRNA,重度组与对照组比较,t =2.891,P =0.001;中度组与对照组比较,t =1.923,P =0.023;轻度组与对照组比较,t =2.011,P =0.019;重度组与中度组比较,t =2.014,P =0.038;重度组与轻度组比较,t =1.911,P =0.031;中重度组与轻度组比较,t =1.021,P =0.089;外周血 RORγt表达量:观察组重度、中度、轻度分别为(1.42±1.71)、(0.89±2.32)、(0.91±1.99),对照组为(0.53±2.06),外周血 RORγtmRNA,重度组与对照组比较,t =2.723,P =0.021;中度组与对照组比较,t =1.993,P =0.015;轻度组与对照组比较,t =1.782,P =0.037;重度组与中度组比较,t =1.875,P =0.041;重度组与轻度组比较,t =2.016,P =0.038;中重度组与轻度组比较,t =1.023,P =0.714;肺泡灌洗液 IL-17表达量:观察组重度、中度、轻度分别为(2.35±1.09)、(1.92±0.21)、(2.01±0.12),对照组为(0.76±0.31),BALF 中IL-17mRNA,重度组与对照组比较,t =2.872,P =0.001;中度组与对照组比较,t =2.51,P =0.021;轻度组与对照组比较,t =1.790,P =0.037;重度组与中度组比较,t =1.689,P =0.031;重度组与轻度组比较,t =1.862, P =0.036;中重度组与轻度组比较,t =1.031,P =0.102;肺泡灌洗液 RORγt 表达量:观察组重度、中度、轻度分别为(2.13±1.42)、(1.42±1.72)、(1.51±2.01),对照组为(0.62±0.25),BALF 中 RORγtmRNA,重度组与对照组比较,t =2.721,P =0.021;中度组与对照组比较,t =2.811,P =0.029;轻度组与对照组比较,t =1.973,P =0.033;重度组与中度组比较,t =1.759,P =0.041;重度组与轻度组比较,t =1.918,P =0.039;中重度组与轻度组比较,t =1.014,P =0.055);且观察组中重度患者的外周血及肺泡灌洗液中的 IL-17、RORγt 的相对表达量高于中、轻度患者,且差异均有统计学意义(P <0.05)。结论支气管哮喘患者的体内存在辅助T 淋巴细胞17(Th17)优势表达,Th17可能在支气管哮喘的发病机制中发挥重要作用。 Objective To detect the expression of Th17 levels about peripheral blood in patients with bron-chial asthma in bronchoalveolar lavage fluid,and to investigate its effect in pathogenesis of bronchial asthmaand. Methods Patients with acute bronchial asthma from 2014 April to 2014 November were collected in the experiment. There are 52 cases as observation group (group of patients with asthma),and the patients were then divided according the severity (mild,moderate,severe);in addition,select 50 healthy people in the same period in our hospital as con-trol group healthy control group.Collect peripheral blood and bronchoalveolar lavage fluid,the expression of specific transcription factors ROR gamma T and cytokine IL -17 in the peripheral blood and bronchoalveolar lavage fluid in Th17 cells levels were detected by real -time fluorescent quantitative PCR.Results The expression of IL -17,ROR gamma T in peripheral blood and bronchoalveolar lavage fluid of the observation group were higher than the control group;the expression of IL -17,ROR gamma T in alveolar lavage fluid quantity and peripheral blood with severe patients in the observation group were higher than that in the mild patients,differences were statistically significant (P 〈0.05).Conclusion There are 17 auxiliary T lymphocytes in patients with bronchial asthma in vivo (Th17) advantage of expression,Th17 may play an important role in the pathogenesis of bronchial asthma.Bronchial asthma patients body may have advantage to heip expression of T lymphocytes 17 (Th17).Th17 may play an important role in the pathogenesis of bronchial asthma.
出处 《中国基层医药》 CAS 2015年第13期2010-2013,共4页 Chinese Journal of Primary Medicine and Pharmacy
关键词 支气管哮喘 辅助 T 淋巴细胞 IL-17 发病机制 聚合酶链反应 Bronchial asthma T helper cell IL -17 Pathogenesis Polymerase chain reaction
  • 相关文献

参考文献14

  • 1杨慧,向平超.支气管哮喘全球倡议(2012更新版)简介[J].中国医学前沿杂志(电子版),2013,5(8):25-29. 被引量:22
  • 2Nakamura K, Kitani A, Strober W. Cell contact-dependent immu- nosuppression by CD4 ( + ) CD25 ( + ) regulatory T cells is men- diated by cellsurface-bound transforming growth factor beta[ J ]. J Exp Med,2001,194 (5) :629-644.
  • 3支气管哮喘防治指南[J].中华结核和呼吸杂志,1997,20(5):261-267. 被引量:2006
  • 4周辰,陈军浩,殷凯生.辅助性T细胞17和调节性T细胞在哮喘小鼠中的失衡表达及其意义[J].中国呼吸与危重监护杂志,2010,9(1):28-31. 被引量:28
  • 5Semik-Orzech A, Barczyk A, Pierzchaia W. The role of interleu- kin17A in inducing neutrophilic inflammation in the pulmonar- ytract[ J]. Pol Merkur Lekarski,2007,22(129) :163-168.
  • 6Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the de- velopment and function of CD4+ CD25+ Regulatory T ceils [ J ]. Nat Immunol,2003,4(4) :330-336.
  • 7Laurence A, Q'shea JJ. T ( H ) -17 differentiation : of mice and men [ J ]. Nat Immunol,2007,8 (9) :903-905.
  • 8Wong CK, Cao J, Yin YB, et al. Interleukin -17A activation on bronchial epithelium and basophils:a novel inflammatory mecha- nism[J]. Eur R espir J,2010,35(4) :883-893.
  • 9Albano GD,Di Sanoal C, Bonanno A, et al. Thl7 immunity in children with allergic asthma and rhinitis: a pharmacologic ap- proach[ J]. PLoS One,2013,8(4) :e58892.
  • 10Korn T, Bettelli E, Oukka M, et al. IL-17 and Thl7 Cells[ J ]. An- nu Rev Immunol,2009,27(4) :485-517.

二级参考文献22

  • 1陈济明,李一禄,黄平,周燕宁,杜秀芳,聂莉.布地奈德对支气管哮喘患者Th17/Treg平衡的干预机制研究[J].中华哮喘杂志(电子版),2012,6(5):329-333. 被引量:10
  • 2罗征秀,肖玲,刘恩梅,陈坤华,黄英,符洲.哮喘儿童不同时期痰液细胞的变化及意义[J].临床儿科杂志,2005,23(9):615-617. 被引量:7
  • 3吴奎,孙鲲,毕玉田,夏俊波,王长征.哮喘小鼠CD4^+CD25^+调节性T细胞数量及功能的改变[J].中国呼吸与危重监护杂志,2005,4(6):455-458. 被引量:16
  • 4陈军浩,吴超,欧阳建,刘勇,顾光煜.CpG-ODN2216刺激健康人外周血淋巴细胞T_H1/T_H2细胞因子的表达[J].临床检验杂志,2007,25(3):192-193. 被引量:4
  • 5Park H, Li Z, Yang XO, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing intcrlcukin 1. Nat Immunol,2005,6 : 1133-1141 .
  • 6Harrington LE, Hatton RD, Mangan PR, et al. Interleukin 17- producing CD4^+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol,2005,6 : 1123-1132.
  • 7Nguyen KD, Fohner A, Booker JD, et al. XCL1 enhances regulatory activities of CD4^+ CD25 (high) CD127 (low/-) T cells in human allergic asthma. J Immunol,2008,181:5386-5395.
  • 8Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature ,2006,441:235-238.
  • 9Semik-Orzech A, Barczyk A, Pierzchaia W. The role of interleukin 17A in inducing neutrophilic inflammation in the puhnonary tract. Pol Merkur Lekarski ,2007,22 : 163-168.
  • 10Bullens DM,Truyen E, Coteur L, et al. IL-17 mRNA in sputum of asthmatic patients : linking T cell driven inflammation and granulocytic influx? Respir Res,2006,7 : 135-138.

共引文献2073

同被引文献24

  • 1Aldubi HM, Missa EM, Kamfar HZ, et al. Bronchial asthma and hypovitaminosis D in Saudi children[J]. Asia Pac Allergy,2015, 5 ( 2 ) : 103-113.
  • 2Wechsler ME, Castro M, Lehman E, et al. Impact of race on asthma treatment failures in the asthma clinical research network [ J ]. Am J Respir Crit Care Med, 2011,184 ( 11 ) : 1247-1253.
  • 3Lin J, Yin K, Su N, et al. Chinese expert consensus on clinical use of non-invasive airway inflammation assessment in bronchial asthma. [J]. Ann Transl Med,2015,7 ( 11 ) :2061-2078.
  • 4Bozek A, Krajewska J, Jarzab J. The improvement of cognitive functions in patients with bronchial asthma after therapy [ J ]. J Asthma,2010,47 ( 10 ) : 1148-1152.
  • 5Ghosh K A, Tripathi P C. Clinical effect of Virechana and Shamana Chikitsa in Tamaka Shwasa ( Bronchial Asthma) [ J ]. Ayu, 2012,33 (2) :238-242.
  • 6Panda A K, Doddanagali S R. Clinical efficacy of herbal Padmapatradi yoga in bronchial asthma (Tamaka Swasa) [ J]. J Ayurveda Integr Med, 2011,2 ( 2 ) : 85-90.
  • 7Yadav S S, Galib, Patgiri B, et al. Clinical efficacy of two different samples of Shirishavaleha in Tamaka Shwasa (Bronchial Asthma)[J]. Ayu, 2012,33 ( 2 ) : 255-260.
  • 8Agarwal R, Noel V, Aggarwal A N, et al. Clinical significance of AspergiUus sensitisation in bronchial asthma[ J ]. Mycoses,2011, 54(5) :e531-e538.
  • 9Dubey A K,Rajagopala S ,Patel K S. Comparative clinical efficacy of Ashtangavaleha and Vyaghreehareetakee Avaleha on Tamaka Shwasa ( bronchial asthma) in children [J].Ayu, 2014,35 ( 4 ) : 384-390.
  • 10Lal D, Manocha S, Ray A, et al. Comparative study of the efficacy and safety of theophylline and doxofylline in patients with bronchial asthma and chronic obstructive pulmonary disease [ J ]. J Basic Clin Physiol Pharmacol, 2015,26 ( 5 ) : 443-451.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部